Keyphrases
Binding Protein
16%
C(X)
16%
Chemokines
16%
Coagulation Pathway
16%
Coagulation-related Genes
16%
Collagen
16%
Complement Component 4
16%
Complement Pathway
16%
Disease Pathogenesis
16%
Disease Pathology
16%
Disease Phenotype
16%
Dynamic State
16%
Extracellular Matrix
16%
Fibrosis
16%
Fibrosis Stage
16%
Gene Expression Pattern
100%
Hepatic Fibrosis
16%
Hepatic Gene Expression
100%
Hepatic Inflammation
16%
Hepatic Steatosis
16%
High-risk Individuals
16%
High-risk Population
16%
IFI30
16%
Incomplete Understanding
16%
Inflammation Pathway
16%
Inflammatory Gene Expression
16%
Interferon-γ-inducible Lysosomal Thiol Reductase
16%
Liver Histology
33%
Liver Injury
16%
Liver Specimen
16%
Liver Tissue
16%
NanoString Technology
16%
NCounter
16%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Nonalcoholic Steatohepatitis
16%
Normal Liver
33%
Obesity
50%
Patients with Obesity
100%
Profibrotic
16%
Proteinase
16%
Scar
16%
Seattle
16%
Steatosis
33%
Tissue Remodeling
33%
Transforming Growth factor-β1 (TGF-β1)
16%
Medicine and Dentistry
Complement Component C4
14%
Diseases
14%
Extracellular Matrix
14%
Fatty Liver
14%
Fibrosis
28%
Gamma Chemokine
14%
Gamma Interferon
14%
Gene Expression
100%
Liver Fibrosis
14%
Liver Histology
28%
Liver Injury
14%
Liver Tissue
14%
Nonalcoholic Fatty Liver
100%
Oxidoreductase
14%
Patient with Obesity
100%
Protease
14%
Protein Binding
14%
Steatosis
28%
Thiol
14%
Transforming Growth Factor Beta1
14%
Immunology and Microbiology
Complement Component 4
33%
Extracellular Matrix
33%
Gamma Chemokine
33%
Gene Expression
100%
Interferon Gamma
33%
Liver Tissue
33%
Protein Binding
33%
Steatohepatitis
33%
Transforming Growth Factor Beta1
33%
Pharmacology, Toxicology and Pharmaceutical Science
Binding Protein
14%
Complement Component C4
14%
Diseases
14%
Fatty Liver
14%
Fibrosis
28%
Gamma Chemokine
14%
Gamma Interferon
14%
Inflammation
28%
Liver Fibrosis
14%
Liver Injury
14%
Nonalcoholic Fatty Liver
100%
Oxidoreductase
14%
Steatosis
28%
Thiol
14%
Transforming Growth Factor Beta1
14%